Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-14

Clinical Trial Update: 3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for adjuvated reduced-dose IPV vaccines and non-adjuvated full-dose IPV as adolescent booster vaccines; Phase 1/Phase 2, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPV SSI vaccines (adjuvated reduced-dose)
  • IPV SSI vaccines (non-adjuvated full-dose)

Snippet

Sponsor: Statens Serum Institut | Conditions: Immunization, Booster | Phase 1, Phase 2 | Status: COMPLETED